Mainz Biomed N V
MYNZ
$1.8+0.03 (+1.69%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 18.40 | 52Week Low | 1.30 |
| Beta | 0.30 | Current Ratio Annual | 1.32 |
| Current Ratio Quarterly | 1.32 | Gross Margin TTM | 64.30 |
| Market Cap | 8.24M | Net Profit Margin TTM | -2,421.80 |
| Operating Margin TTM | -2,088.06 | Price To Book | 1.36 |
| Price To Sales TTM | 9.22 | Quick Ratio Annual | 1.11 |
| Quick Ratio Quarterly | 1.11 | Return On Assets TTM | -199.62 |
| Return On Equity TTM | -175.75 | Return On Investment TTM | -128.24 |
| Revenue Growth3Y | 15.51 | Revenue Growth5Y | 26.13 |
| Revenue Growth Quarterly Yoy | 73.78 | Revenue Growth TTMYoy | -0.27 |
| Revenue Per Share TTM | 0.65 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 0 | 0 | 0 | 0 | 245.33K | $980.72K |
| Mar 31, 2025 | 12(+50%) | 4(+300%) | 0 | 2(+%) | 4(+%) | 1(+%) | 234.90K(-4%) | $721.21K(-26%) |
| Jun 30, 2025 | 12 | 4 | 2(+%) | 4(+100%) | 0(-100%) | 2(+100%) | 383.15K(+63%) | $540.25K(-25%) |